Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine development

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Gene Therapy

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1038/sj.gt.3300500PMID 9415312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue engineering.

  1998cited by this paper
• Comparison of Retroviral and Adeno-Associated Viral Vectors Designed to Express Human Clotting Factor IX

  1997cited by this paper
• Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.

  1997cited by this paper
• Leptin Receptor Action in Hepatic Cells*

  1997cited by this paper
• Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients

  1996cited by this paper
• Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer.

  1996cited by this paper
• Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

  1996cited by this paper
• Receptors for Interleukin (IL)-10 and IL-6-type Cytokines Use Similar Signaling Mechanisms for Inducing Transcription through IL-6 Response Elements*

  1996cited by this paper
• Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine

  1996cited by this paper
• Retrovirus-Mediated Gene Expression in Hematopoietic Cells Correlates Inversely with Growth Factor Stimulation

  1996cited by this paper
• Retroviral Vectors for Production of Interleukin‐12 in the Bone Marrow to Induce a Graft‐Versus‐Leukemia Effect a

  1996cited by this paper
• Antigens recognized on human tumors by cytolytic T lymphocytes: Towards vaccination?

  1995cited by this paper
• R-Region cDNA Inserts in Retroviral Vectors Are Compatible with Virus Replication and High-Level Protein Synthesis from the Insert

  1995cited by this paper
• Soluble interleukin 6 receptor is biologically active in vivo.

  1995cited by this paper
• Induction of anti-self-immunity to cure cancer.

  1995cited by this paper
• Paracrine cytokine adjuvants in cancer immunotherapy.

  1995cited by this paper
• A Retroviral Vector Containing a Muscle-Specific Enhancer Drives Gene Expression Only in Differentiated Muscle Fibers

  1995cited by this paper
• Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen.

  1995cited by this paper
• Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro.

  1995cited by this paper
• IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts.

  1995cited by this paper
• Gene therapy of human melanoma. Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptor.

  1995cited by this paper
• Gene transfer technologies for the gene therapy of cancer.

  1994cited by this paper
• Hematopathology of interleukin 6-type cytokines.

  1994cited by this paper
• A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes.

  1994cited by this paper
• Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.

  1994cited by this paper
• Versatile retroviral vectors for potential use in gene therapy.

  1994cited by this paper
• The basic science of gene therapy.

  1993cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• High efficiency gene transfer into primary human tumor explants without cell selection.

  1993cited by this paper
• Tissue engineering.

  1993cited by this paper
• Use of retroviral vectors for gene transfer and expression.

  1993cited by this paper
• Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations.

  1993cited by this paper
• Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.

  1992cited by this paper
• A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma.

  1992cited by this paper
• Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins.

  1992cited by this paper
• Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus

  1992cited by this paper
• In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells.

  1992cited by this paper
• Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes.

  1991cited by this paper
• Retroviral-mediated gene transfer into hepatocytes in vivo.

  1991cited by this paper
• Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene

  1991cited by this paper
• The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos

  1991cited by this paper
• Interleukin-6: an overview.

  1990cited by this paper
• Antitumor activity of recombinant interleukin 6 in mice

  1990cited by this paper
• Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells.

  1990cited by this paper
• Human melanoma: Development and progression

  1990cited by this paper
• Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector.

  1989cited by this paper
• An improved retroviral vector for gene transfer into undifferentiated cells.

  1989cited by this paper
• Improved retroviral vectors for gene transfer and expression.

  1989cited by this paper
• Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines.

  1989cited by this paper
• Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130.

  1989cited by this paper
• A safe packaging line for gene transfer: separating viral genes on two different plasmids

  1988cited by this paper
• Use of a recombinant retrovirus to study post‐implantation cell lineage in mouse embryos.

  1986cited by this paper
• Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

  1986cited by this paper
• The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines

  1985cited by this paper
• Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism.

  1984cited by this paper

• Expression of Secreted Neutrophil Gelatinase-Associated Lipocalin in 293T Cell Using the Inducible Dual-Function System

  2021cites this paper
• Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients

  2018cites this paper
• Therapeutic gene modified cell based cancer vaccines.

  2013cites this paper
• Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR.

  2009cites this paper
• Reducing the genotoxic potential of retroviral vectors.

  2008cites this paper
• Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions

  2006cites this paper
• A NEW REPORTER GENE TECHNOLOGY: OPPORTUNITIES AND PERSPECTIVES

  2005cites this paper
• Tumour‐infiltrating lymphocytes and melanoma tumorigenesis: an insight

  2005cites this paper
• Human cancer gene therapy with cytokine gene-modified cells

  2004cites this paper
• Effect of cyclophosphamide on tumorogenesis of the IL-6 and Hyper-IL-6 gene modified murine melanoma cells

  2004cites this paper
• The application of magnetic resonance imaging and spectroscopy to gene therapy.

  2004cites this paper
• Interaktion von Leukozyten mit endothelialen Adhäsionsmolekülen und ihre Inhibition durch Expression von konkurrierenden Fusionsproteinen

  2002cites this paper
• Adeno‐cosmid cloning vectors for regulated gene expression

  2002cites this paper
• Molecular imaging and gene therapy.

  2001cites this paper
• Imaging of Gene Delivery and Expression

  2001cites this paper
• “Rainbow” Reporters for Multispectral Marking and Lineage Analysis of Hematopoietic Stem Cells

  2001cites this paper
• Facilitation of Organ Transplantation with Gene Therapy

  2001cites this paper
• Evaluation of Retroviral Vector Design in Defined Chromosomal Loci by Flp-Mediated Cassette Replacement

  2001cites this paper
• Antitumor effects of the combination therapy with TNF-α gene–modified tumor cells and interleukin 12 in a melanoma model in mice

  2000cites this paper
• The use and development of retroviral vectors to deliver cytokine genes for cancer therapy.

  2000cites this paper
• Gene Electrotransfer Results in a High-Level Transduction of Rat Skeletal Muscle and Corrects Anemia of Renal Failure

  2000influential citation
• β-Galactosidase marker genes to tag and track human hematopoietic cells

  1999cites this paper
• MHC Class II alpha/beta Heterodimeric Cell Surface Molecules Expressed from a Single Proviral Genome

  1999cites this paper
• Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer

  1999cites this paper
• Reporter gene technology: the future looks bright.

  1999cites this paper
• Beta-galactosidase marker genes to tag and track human hematopoietic cells.

  1999cites this paper
• Gene therapy in transplantation

  1999cites this paper
• Development of double copy dicistronic retroviral vectors for transfer and expression of glycosyltransferase genes.

  1998cites this paper
• Immunogene therapy of human melanoma. Phase I/II clinical trial.

  1998cites this paper
• More about genetically modified tumour vaccines

  1998cites this paper
• Gene therapy of cancer

  1996cites this paper
• Effect of irradiation on interleukin 6 and soluble interleukin 6 receptor modified melanoma genetic vaccine

  1996cites this paper